kidney stones and glp-1 Do drugs have health risks beyond their weight loss benefits? GLP-1 and Kidney Stones: Risk

The comparative efficacy in CKM syndrome components is summarized in Table 1

If back pain persists despite conservative measures or significantly impacts quality of life, clinicians should reassess the benefit-risk ratio of continuing therapy

All told, Mounjaro and other medications in the GLP-1 family are thought to help lower your set point: the weight your body naturally settles at due to an interplay of genetics, biology, and environment

Sources: Global Glucagon-like Peptide 1 (GLP-1) Market Analysis Report 2023: Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH Gaining Momentum. GlobeNewswire, January 30, 2023

Your care team will adjust dosing as needed

Medication list: insulin, sulfonylureas, or other glucose-lowering drugs